CM
HGEN

CM Management’s HUMANIGEN, INC. HGEN Stock Holding History

CM Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,000
Closed -$478K – 96
2021
Q1 		$478K Sell
25,000
-15,000
-38% -$274K 0.36% 73
2020
Q4 		$700K Buy
+40,000
New +$479K 0.65% 50

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CM Management's HGEN Position: Q2 2021 in Review

CM Management sold out of HUMANIGEN, INC. (HGEN) in Q2 2021, closing a stake of 25,000 shares — an estimated $478K sold.

CM Management first reported a position in HGEN in Q4 2020 and held it in 2 quarters. The position peaked at $700K in Q4 2020. 92 funds tracked by Wall St. Rank hold HGEN as of Q2 2021.

  • CM Management reported no remaining HUMANIGEN, INC. position as of Q2 2021 after selling out during the quarter.
  • CM Management sold 25,000 HUMANIGEN, INC. shares in Q2 2021, an estimated $478K.
  • CM Management first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 2 quarters.
  • CM Management's HUMANIGEN, INC. position peaked at $700K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2021.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.